It is thought that the above-described tumor-induced MSPC-mediated recruitment of various immune cells and modulation towards an anti-inflammatory, immunosuppressive environment also occurs in MDS and AML, fostering immune escape of the dysplastic/leukemic clone in general, and of NSCs in particular. Here, NLRP1 is linked to myelodysplastic syndrome.